Ticker

A Deep Dive into the Small-Cap Pioneer's Latest Moves, Including a -0.42% Impact from Exiting a Major StakeCharles M. Royce, a pioneer of small-cap investing an

California State Teachers Retirement System raised its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) by 27.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 140,716 shares of the biopharmaceutical company's stock after purchasing an additional 30,717 shares during the quarter.

Angelini Pharma said on Thursday it had completed the acquisition of U.S. rare-disease drug maker ​Catalyst Pharmaceuticals in a $4.1 billion deal involving ‌Italian state lender CDP.

The Italian pharma company grows its presence in the U.S. market and strengthens its global leadership in Brain Health and Rare Diseases Completion of the transaction gives Angelini Pharma ownership of Catalyst's product portfolio The transaction is being carried out with the participation of funds managed by Blackstone CDP Equity approves €1 billion investment in Angelini Pharma Italy remains a strategic production…

Catalyst Pharmaceuticals NASDAQ: CPRX stockholders approved the company's proposed merger with Angelini Pharma S.p.A. at a special meeting held virtually on July 8, according to remarks from company officials during the meeting.